Cite
HARVARD Citation
Sandhu, S. et al. (2022). Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib. Case reports in hepatology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sandhu, S. et al. (2022). Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib. Case reports in hepatology. p. . [Online].